Ep 126 [07 February 2024]: Winson Cheung MD MPH – HTA and regulatory acceptability of RWE in oncology

Ep 126 [07 February 2024]: Conversation with Winson Cheung MD MPH, Co-Founder at Inka Health – We discussed the assessment/grading of RWE in oncology for HTA & regulators, and what is acceptable in the absence of a randomized clinical trial.

Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.